The film, which garnered over 243,000 views within its first 24 hours, documents the oxidation process, HPLC analysis, and purification methods used to synthesize 7-OH. Company founder Vince Sanders granted Morris unrestricted access to the site, aiming to counter industry criticism through transparency. While the documentary features voices labeling the compound dangerously addictive, Morris advocates against strict prohibition, arguing it hinders necessary scientific inquiry.

The regulatory pressure centers on a proposed 0.050 percent threshold for 7-OH, a move currently under review by the Department of Health and Human Services. With over 8,900 public comments submitted, the debate highlights a significant divide between federal agencies and industry players. CBD American Shaman has requested clarity on the scientific derivation of the threshold, while policy groups like the Cato Institute and R Street Institute have voiced skepticism regarding the potential for an emergency Schedule I classification. The Drug Enforcement Administration is barred from issuing such an order before August 5, 2026.